When we compared patients above and below the median of apoA-IV concentrations we barely missed significance in terms of a lower odds for a history of cancer in patients above the median of apoA-IV with an OR = 0.84 (95% CI 0.70–1.02, p = 0.07) (Table 2). This evidence concerns the gene APOA4 and cancer.